Magnitude Biosciences secures funding to boost AI-powered drug discovery
BusinessLive - 27-Jun-2025Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Join the club for FREE to access the whole archive and other member benefits.
Innovator, Transformative Leadership and CEO at Magnitude Biosciences
Fozia’s role within Magnitude is to lead and deliver the strategy and vision for growth of the business.
Fozia is passionate about delivering profitable innovations by effectively leading multifunctional teams. Along with the experts at Magnitude, she is committed to delivering a bespoke service to our clients tailored to answering their specific research questions. Fozia joined us with over 14 years senior leadership experience across the medical device, pharmaceutical and nicotine industries. She has extensive experience of working in the global life sciences sector in R&D, CRO and GTM environments.
Fozia has a PhD in molecular physiology from the University of Edinburgh and started her career in industry at GlaxoSmithKline. She subsequently worked for British American Tobacco and Nicoventures Holdings where she had a wide range of responsibilities, including product development, project delivery and revenue growth.
Visit website: https://magnitudebiosciences.com/team-members/dr-fozia-saleem/
See also
Biotechnology company that combines experience in ageing research, the nematode C. elegans and automation
Details last updated 19-Nov-2022
Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Biotechnology company that combines experience in ageing research, the nematode C. elegans and automation